> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 510(k) Clearance for CardioWise Heart Analysis Software
- URL: https://www.fdaweb.com/510-k-clearance-for-cardiowise-heart-analysis-software/
- Published: 2021-01-06T12:00:00.000Z
- Updated: 2026-09-14T16:41:36.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5148394

FDA has cleared the CardioWise Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ), an image analysis software application for cardiac computer tomography (CT) studies to assist cardiologists and radiologists in assessing function when producing a cardiac evaluation. The company [says](https://www.marketwatch.com/press-release/cardiowisetm-receives-us-fda-510k-clearance-for-stretch-quantifier-for-endocardial-engraved-zones-squeez-heart-function-analysis-software-2021-01-06?tesla=y&ref=fdaweb.com) SQuEEZ is based on the ability in sequential high-resolution cardiac CT scans to track movement of individual points on the endocardium during the contraction of the heart. “The analysis of SQuEEZ parameters has the potential to improve the ability to quantify accurately the ability of the heart to pump blood through the left ventricle,” CardioWise says.